Literature DB >> 36189817

Lamin A precursor localizes to the Z-disc of sarcomeres in the heart and is dynamically regulated in muscle cell differentiation.

Daniel Brayson1,2, Catherine M Shanahan2.   

Abstract

The lamin A precursor, prelamin A, requires extensive processing to yield mature lamin A and effect its primary function as a structural filament of the nucleoskeleton. When processing is perturbed, nuclear accumulation of prelamin A is toxic and causes laminopathic diseases such as Hutchinson-Gilford progeria syndrome and cardiomyopathy. However, the physiological role of prelamin A is largely unknown and we sought to identify novel insights about this. Using rodent heart tissue, primary cells and the C2C12 model of myofibrillogenesis, we investigated the expression and localization patterns of prelamin A in heart and skeletal muscle cells. We found that endogenous prelamin A was detectable in mouse heart localized to the sarcomere in both adult mouse heart and isolated neonatal rat cardiomyocytes. We investigated the regulation of prelamin A in C2C12 myofibrillogenesis and found it was dynamically regulated and organized into striations upon myofibril formation, colocalizing with the Z-disc protein α-actinin. These data provide evidence that prelamin A is a component of the sarcomere, underpinning a physiological purpose for unprocessed prelamin A. This article is part of the theme issue 'The cardiomyocyte: new revelations on the interplay between architecture and function in growth, health, and disease'.

Entities:  

Keywords:  heart; lamin A; muscle; prelamin A; sarcomere

Mesh:

Substances:

Year:  2022        PMID: 36189817      PMCID: PMC9527914          DOI: 10.1098/rstb.2021.0490

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.671


  31 in total

1.  DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A.

Authors:  Yiyong Liu; Antonio Rusinol; Michael Sinensky; Youjie Wang; Yue Zou
Journal:  J Cell Sci       Date:  2006-10-24       Impact factor: 5.285

2.  A myogenic cell line with altered serum requirements for differentiation.

Authors:  D Yaffe; O Saxel
Journal:  Differentiation       Date:  1977       Impact factor: 3.880

3.  Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome.

Authors:  Leslie B Gordon; Monica E Kleinman; David T Miller; Donna S Neuberg; Anita Giobbie-Hurder; Marie Gerhard-Herman; Leslie B Smoot; Catherine M Gordon; Robert Cleveland; Brian D Snyder; Brian Fligor; W Robert Bishop; Paul Statkevich; Amy Regen; Andrew Sonis; Susan Riley; Christine Ploski; Annette Correia; Nicolle Quinn; Nicole J Ullrich; Ara Nazarian; Marilyn G Liang; Susanna Y Huh; Armin Schwartzman; Mark W Kieran
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

4.  Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction.

Authors:  Jan Lammerding; P Christian Schulze; Tomosaburo Takahashi; Serguei Kozlov; Teresa Sullivan; Roger D Kamm; Colin L Stewart; Richard T Lee
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

5.  Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome.

Authors:  Robert D Goldman; Dale K Shumaker; Michael R Erdos; Maria Eriksson; Anne E Goldman; Leslie B Gordon; Yosef Gruenbaum; Satya Khuon; Melissa Mendez; Renée Varga; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

6.  Proteomic analysis identifies key differences in the cardiac interactomes of dystrophin and micro-dystrophin.

Authors:  Hong Wang; Elena Marrosu; Daniel Brayson; Nalinda B Wasala; Eric K Johnson; Charlotte S Scott; Yongping Yue; Kwan-Leong Hau; Aaron J Trask; Stan C Froehner; Marvin E Adams; Liwen Zhang; Dongsheng Duan; Federica Montanaro
Journal:  Hum Mol Genet       Date:  2021-06-26       Impact factor: 6.150

7.  Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy.

Authors:  T Sullivan; D Escalante-Alcalde; H Bhatt; M Anver; N Bhat; K Nagashima; C L Stewart; B Burke
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

Review 8.  Current insights into LMNA cardiomyopathies: Existing models and missing LINCs.

Authors:  Daniel Brayson; Catherine M Shanahan
Journal:  Nucleus       Date:  2017-01-02       Impact factor: 4.197

9.  The processing pathway of prelamin A.

Authors:  M Sinensky; K Fantle; M Trujillo; T McLain; A Kupfer; M Dalton
Journal:  J Cell Sci       Date:  1994-01       Impact factor: 5.285

10.  Prelamin A causes aberrant myonuclear arrangement and results in muscle fiber weakness.

Authors:  Yotam Levy; Jacob A Ross; Marili Niglas; Vladimir A Snetkov; Steven Lynham; Chen-Yu Liao; Megan J Puckelwartz; Yueh-Mei Hsu; Elizabeth M McNally; Manfred Alsheimer; Stephen Dr Harridge; Stephen G Young; Loren G Fong; Yaiza Español; Carlos Lopez-Otin; Brian K Kennedy; Dawn A Lowe; Julien Ochala
Journal:  JCI Insight       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.